한빛사390건

• • 김재원(서울대학교 의과대학)

  Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

  • Lancet Oncol. Sep 2024, 25 (9) S1470-2045(24)00192-X | https://doi.org/10.1016/S1470-2045(24)00192-X

  • 2024.09

• • 조민수(울산대학교 의과대학, 서울아산병원)

  • 강도윤(울산대학교 의과대학, 서울아산병원)

  • 박덕우(울산대학교 의과대학, 서울아산병원)

  • 남기병(울산대학교 의과대학, 서울아산병원)

  Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease

  • N. Engl. J. Med. 2024 Sep 1| https://www.nejm.org/doi/10.1056/NEJMoa2407362

  • 2024.09
  • 의약학

• • 홍성진(연세대학교 의과대학, 세브란스병원)

  • 홍명기(연세대학교 의과대학)

  De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systema

  • Lancet Aug 30 2024, S0140-6736(24)01616-7 | https://doi.org/10.1016/S0140-6736(24)01616-7

  • 2024.08
  • 의약학

• • 김률(Inocras Inc.)

  • 김석휘(아주대학교 의과대학)

  • 오백록(Inocras Inc.)

  • 주영석(Inocras Inc.)

  • 권민석(아주대학교병원 종양혈액내과, 삼성서울병원 혈액종양내과)

  Clinical application of whole-genome sequencing of solid tumors for precision oncology

  • Exp. Mol. Med. 13 August 2024 | https://doi.org/10.1038/s12276-024-01288-x

  • 2024.08

• • 신안나(분당서울대학교병원)

  • 강은하(분당서울대학교병원)

  Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years wit

  • Br. Med. J. Aug 28 2024, 386 e079475 | https://doi.org/10.1136/bmj-2024-079475

  • 2024.08

• • 이장순(University of Hawai'I Cancer Center)

  • 임석아(서울대학교 의과대학)

  The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overex

  • J. Exp. Clin. Cancer Res. Aug 21 2024, 43 (1) 236 | https://doi.org/10.1186/s13046-024-03143-3

  • 2024.08

• • 문석준(한양대학교)

  • 조은이(한양대학교)

  • 길우진(한양대학교)

  • 양철수(한양대학교)

  Dual alarmin-receptor-specific targeting peptide systems for treatment of sepsis

  • Acta Pharm. Sin. B Available online 19 August 2024 | https://doi.org/10.1016/j.apsb.2024.08.015

  • 2024.08
  • 생명과학

• • 이지훈(전남대학교)

  Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies

  • Cancer Treat. Rev. Aug 05 2024, 129 S0305-7372(24)00136-1 | https://doi.org/10.1016/j.ctrv.2024.102808

  • 2024.08

• • 조창훈(Genentech, Inc.)

  Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonism

  • Alzheimers. Dement. Aug 01 2024, | https://doi.org/10.1002/alz.13921

  • 2024.08
• 

  성예원

  NIH

  We study cisplatin, which is a widely used and effective anticancer drug, but it has significant side effects, including ototoxicity (hearing loss) and nephrotoxicity (kidney injury), in pediatric and adult cancer patients. In this paper, we investigated the role of macrophages in cisplatin-induced hearing loss and kidney injury in mice.

  • Sci. Adv.
  • 2024.08.21

• • 김현(Columbia University)

  Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer‘s Disease Prevention Trials (NoMAD) project: Psychome

  • Alzheimers. Dement. Jul 04 2024, | https://doi.org/10.1002/alz.13757

  • 2024.07

• • 김종한(University of Massachusetts Lowell)

  • 최학수(Massachusetts General Hospital and Harvard Medical School)

  Nanotherapeutic kidney cell-specific targeting to ameliorate acute kidney injury

  • Kidney Int. July 24, 2024 | https://doi.org/10.1016/j.kint.2024.06.021

  • 2024.07
  • 바이오·의료융합

• • Chanutchamon Sutthiwanjampa(중앙대학교)

  • 강신혁(중앙대학교)

  • 박한수(중앙대학교)

  Tumor necrosis factor-α-treated human adipose-derived stem cells enhance inherent radiation tolerance and alleviate in vivo radiation-induced capsula

  • J. Adv. Res. Jul 15 2024, S2090-1232(24)00295-9 | https://doi.org/10.1016/j.jare.2024.07.011

  • 2024.07
  • 바이오·의료융합

• • 강윤구(울산대학교 의과대학)

  Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes Fr

  • J. Clin. Oncol. Jul 12 2024, | https://doi.org/10.1200/JCO.23.02167

  • 2024.07
  • 생명과학
• 

  Javeria Zaheer

  한국원자력의학원

  Microplastics (MPs) are tiny particles (

  • J. Hazard. Mater.
  • 2024.07.29

• • 서현민(한양대학교 구리병원)

  • 최광성(인하대학교 의과대학)

  Phase I/II trials of human bone marrow-derived clonal mesenchymal stem cells for treatment of adults with moderate-to-severe atopic dermatitis

  • J. Allergy Clin. Immunol. Jun 27 2024, S0091-6749(24)00637-7 | https://doi.org/10.1016/j.jaci.2024.06.013

  • 2024.06
  • 의약학

• • 황상연(University of Calgary, 동남권원자력의학원)

  Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy,

  • Liver Cancer Jun 2024, 13 (3) | https://doi.org/10.1159/000534303

  • 2024.06

• • 이대훈(경희대학교 약학대학, 큐리진)

  • 최진우(경희대학교 약학대학)

  Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment

  • J. Exp. Clin. Cancer Res. Jun 18 2024, 43 (1) | https://doi.org/10.1186/s13046-024-03088-7

  • 2024.06

• • 이은비(울산대학교 의과대학)

  • 고진영(울산대학교 의과대학)

  • 김승후(울산대학교 의과대학)

  • 김헌식(울산대학교 의과대학)

  CEACAM1-engineered MSCs have a broad spectrum of immunomodulatory functions and therapeutic potential via cell-to-cell interaction

  • Biomaterials Jun 14 2024, 311 S0142-9612(24)00201-1 | https://doi.org/10.1016/j.biomaterials.2024.122667

  • 2024.06
  • 의약학

• • 김태완(DGIST)

  • 구소연(Sloan Kettering Cancer Center, Weill Cornell Medicine)

  TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons

  • Cell June 11, 2024 | https://doi.org/10.1016/j.cell.2024.05.030

  • 2024.06
  • 생명과학